StocksInsight

MCHP Stock vs the S&P 500: Returns, Risk and Crash History

Microchip Technology Incorporated, technology (market value $42.3 billion), a member of the S&P 500 and the Nasdaq‑100: how it compared with the S&P 500, how it behaved in every crash since 2008, its risk‑adjusted returns and what analysts said. Returns to Oct 30, 2026; analyst data as of Nov 9, 2026.

Published Updated 4 min readHow we research

Key takeaways

  • MCHP returned +16.4% over the 5 years to Oct 30, 2026 versus +75.9% for the S&P 500: it lagged the index.
  • Its 5-year Sharpe ratio was 0.19 against 0.58 for the S&P 500.
  • Its deepest crisis drawdown was −56.5% in the global financial crisis (2007–09) (S&P 500: −56.5%).
  • Five‑year volatility was 43.5% and beta 1.84.
  • 24 analysts rated it in the past year; 78% of their latest calls were Buy.
  • MCHP beat earnings estimates in 9 of its last 12 reports; the stock moved 6.1% on average, up or down, around each report.

What do the best‑ranked analysts on MCHP say now? See it in Exent Gems →

Did MCHP beat the S&P 500?

Over the 5 years to Oct 30, 2026, Microchip Technology Incorporated (MCHP) returned +16.4% including dividends, versus +75.9% for the S&P 500 (SPY). It lagged the index by 59.5 percentage points, or +3.1% a year against +12.0%.

PeriodMCHPS&P 500MCHP per yearS&P 500 per yearResult
1 year+27.1%+12.0%+27.1%+12.0%Beat
3 years+17.0%+87.4%+5.4%+23.3%Lagged
5 years+16.4%+75.9%+3.1%+12.0%Lagged
10 years+208.5%+316.3%+11.9%+15.3%Lagged
  • 1 year
    MCHP
    +27.1%
    S&P 500
    +12.0%
    MCHP per year
    +27.1%
    S&P 500 per year
    +12.0%
    Result
    Beat
  • 3 years
    MCHP
    +17.0%
    S&P 500
    +87.4%
    MCHP per year
    +5.4%
    S&P 500 per year
    +23.3%
    Result
    Lagged
  • 5 years
    MCHP
    +16.4%
    S&P 500
    +75.9%
    MCHP per year
    +3.1%
    S&P 500 per year
    +12.0%
    Result
    Lagged
  • 10 years
    MCHP
    +208.5%
    S&P 500
    +316.3%
    MCHP per year
    +11.9%
    S&P 500 per year
    +15.3%
    Result
    Lagged

Total return with dividends reinvested, from month-end prices to Oct 30, 2026. Beating the index on raw return is only half the story: the next section adjusts for the risk taken. See also how to beat the S&P 500.

MCHP is in the S&P 500 and the Nasdaq‑100 (members as of Oct 20, 2026); the lists show every member’s return against the index.

What Wall Street analysts say about MCHP

In the 12 months to 30 days ago, 24 analysts published 238 ratings on MCHP. Their latest calls were 78% Buy, 22% Hold and 0% Sell. 23 of them rank 4★ or higher in Exent’s analyst scoring, which is based on each analyst’s past price‑target hit rate and returns.

The consensus 12‑month price target was $100.60 (range $88.00–$120.00), +66.7% from the last price. Remember that the average analyst’s target is hit only about half the time: how accurate are price targets?

Top‑ranked analyst coveringFirmStarsPrice‑target hit rate
??????5.0★67.3%
??????5.0★60.0%
??????5.0★63.2%
??????5.0★59.0%
??????5.0★69.3%

Other analysts covering MCHP: Melissa Fairbanks · Mark Lipacis · Matthew Prisco · Blayne Curtis · Thomas O'Malley · Joshua Buchalter

Ratings are shown with a 30‑day delay. Who the top‑ranked analysts on MCHP are, their live calls and the median target of only the top‑rated analysts are in Exent Gems.

The average analyst’s target is reached about 53.1% of the time; Exent Gems is built on the top 50 of Exent’s ranking,where some reached 90% or more over the last two years. Unlock the top 50 analysts.

MCHP returns by year vs the S&P 500

MCHP beat the S&P 500 in 5 of the 9 full calendar years shown.

YearMCHPS&P 500Difference
2026 (to Oct 30, 2026)+23.4%+11.7%+11.7%
2025+14.6%+17.7%−3.1%
2024−35.0%+24.9%−59.9%
2023+30.9%+26.2%+4.7%
2022−18.0%−18.2%+0.2%
2021+27.5%+28.7%−1.2%
2020+33.7%+18.3%+15.4%
2019+48.1%+31.2%+16.9%
2018−16.7%−4.6%−12.1%
2017+39.5%+21.7%+17.8%

MCHP risk-adjusted returns: Sharpe, Sortino and volatility

Over 5 years, MCHP had a Sharpe ratio of 0.19 against 0.58 for the S&P 500, so it earned less return per unit of risk than the index. Its annualized volatility was 43.8% and its beta 1.84: it tended to move about 1.8× as much as the market.

MetricMCHPS&P 500
Annual return+3.1%+12.0%
Volatility (annualized)43.8%15.5%
Sharpe ratio0.190.58
Sortino ratio0.330.91
Max drawdown (month-end)−51.7%−23.9%
Beta to the S&P 5001.841.00

Sharpe divides return above cash by total volatility; Sortino counts only downside volatility. Both use monthly returns and the 1–3 month T‑bill ETF (BIL) as the risk‑free rate.

How MCHP behaved in past crashes

MCHP’s deepest fall in the crises below was −56.5% in the global financial crisis (2007–09), against −56.5% for the S&P 500. The last column turns that into money: what a $100,000 position would have lost from peak to trough.

CrisisMCHPS&P 500Loss on $100,000
Global financial crisis (2007–09)−56.5%−56.5%−$56,480
2018 trade-war selloff−26.5%−20.2%−$26,480
COVID crash (Feb–Mar 2020)−49.2%−34.1%−$49,210
2022 inflation bear market−36.2%−25.4%−$36,200
2025 tariff selloff−45.0%−19.0%−$45,040
WindowMCHP max drawdown
Last 1 year−34.4%
Last 3 years−63.8%
Last 5 years−63.8%
Last 10 years−64.5%

Peak‑to‑trough declines from daily prices inside each crisis window. A crash replay does not predict the next crisis; it shows how much room a holding needs. Run the same replay on a whole portfolio with the crash test.

What moves with MCHP, and what doesn’t

Correlation runs from −1 (moves opposite) to +1 (moves in lockstep). Over the last 60 months of monthly returns, MCHP’s correlation with the S&P 500 was 0.65, with the Nasdaq‑100 0.66, with long Treasuries (TLT) 0.36 and with gold (GLD) 0.06.

Adding a 5% MCHP position to an S&P 500 portfolio would have moved its 5‑year volatility from 15.5% to 16.2%.

Least correlated large capsCorrelationMost correlated large capsCorrelation
MRK−0.17TXN0.80
REGN−0.11ADI0.80
CME−0.11AMD0.60
BMY−0.08LRCX0.59
MCK−0.08WDC0.59

Holdings that are highly correlated behave like one position in a selloff. See how to find hidden overlap.

Latest MCHP upgrades, downgrades and price‑target changes

DateRating and targetAnalyst
Nov 6Target cut
Buy
Target $85, was $100
Blayne Curtis
Jefferies
Nov 6Target cut
Buy
Target $80, was $125
Melissa Fairbanks
Raymond James
Nov 6Target cut
Hold
Target $70, was $80
Joseph Quatrochi
Wells Fargo
Nov 6Target cut
Buy
Target $100, was $115
James Schneider
Goldman Sachs
Nov 6Target cut
Buy
Target $80, was $100
Vivek Arya
Bank of America Securities
Nov 6Target cut
Buy
Target $88, was $108
Tore Svanberg
Stifel Nicolaus
Nov 6New coverage
Buy
Target $85, was $98
Craig Ellis
B. Riley Securities
Nov 6Target cut
Hold
Target $90, was $105
Thomas O'Malley
Barclays
Nov 5Target cut
Buy
Target $100, was $125
Matthew Prisco
Cantor Fitzgerald
Oct 22Target cut
Buy
Target $98, was $108
Craig Ellis
B. Riley Securities
Oct 20Target cut
Hold
Target $80, was $88
Joseph Quatrochi
Wells Fargo

Named analysts’ rating and price‑target changes on MCHP in the 5 weeks to Oct 12, 2026, shown 30 days after publication (the free analysts’ calls 3 days after). The top‑ranked analysts’ calls are in Exent Gems. See all of the latest analyst upgrades and downgrades.

Do analysts get MCHP right?

Of the 461 analyst price targets on MCHP set from 2019 until a year ago, 67.7% were reached within 12 months (data to Oct 20, 2026), 0.9 points below the 68.6% hit rate of the median stock in Exent’s study of 794 stocks. Targets that were reached took a median of 71 days. The median target sat 18.3% above the share price on the day it was set.

Where analysts said MCHP would be by now: a year ago, 13 analysts had a price target on MCHP, and the median of their latest targets was $75.00. On Oct 20, 2026 MCHP closed at $75.85, 1.1% above it.

67.7%of targets reached within 12 monthsMedian stock: 68.6%
71 daysmedian time to reach a target
+1.1%price now vs the median target set a year ago
AfterCallsMove on the call3 months vs S&P 500
Upgrades of MCHP14+1.8%+2.4%
Upgrades, all stocks11,514+2.5%+3.4%
Downgrades of MCHP7−2.8%−3.4%
Downgrades, all stocks10,700−3.0%−1.6%

The move on the call runs from the close before the rating change to the close after it; the last column is the stock’s return minus the S&P 500’s over the next three months. Averages of rating changes on MCHP through Sep 15, 2026; analysts are not named here. Do analyst upgrades move stocks?

How MCHP moves after earnings

MCHP beat the consensus earnings‑per‑share estimate in 9 of its last 12 quarterly reports, through the one on Aug 6, 2026, and the revenue estimate in 7 of 12. From the close before each report to the close after it, the stock moved 6.1% on average, up or down, against 6.8% for the average report across the 1,002 US stocks Exent tracks. It rose after 4 of the 12 reports. In 7 of the 9 beats the stock still fell.

9/12earnings beats
±6.1%average move per report
4/12reports followed by a rise
ReportEPS vs estimateRevenue vs estimateStock move
Aug 6, 2026$0.76 vs $0.70+1.8%+8.9%
May 7, 2026$0.57 vs $0.51+3.8%−3.7%
Feb 5, 2026$0.44 vs $0.43+0.2%−2.8%
Nov 6, 2025$0.35 vs $0.33+0.7%−7.4%
Aug 7, 2025$0.27 vs $0.24+1.7%−6.5%
May 8, 2025$0.11 vs $0.10+0.8%+15.1%
Feb 6, 2025$0.20 vs $0.28−1.9%−3.0%
Nov 5, 2024$0.46 vs $0.43+1.0%−1.0%

Reported earnings per share against the consensus estimate, revenue surprise in percent, and the stock’s price change over the two sessions around the report. How stocks move after earnings

Where MCHP’s revenue comes from

In fiscal 2026, MCHP’s largest segment was Semiconductor Products Member, with 96.5% of $4.7 billion revenue (+6.5% on the year before).

SegmentRevenueShareGrowth
Semiconductor Products Member$4.5 billion96.5%+6.5%
Technology Licensing Member$163.8 million3.5%+24.9%

From MCHP’s annual filings; segment growth compares fiscal 2026 with the year before. Regions are as each company reports them, so one company’s “Asia Pacific” is not another’s. China counts the regions a company reports as China, Greater China or Hong Kong; a separately reported Taiwan is not counted. Which S&P 500 companies depend most on China?

Members of Congress who traded MCHP

As of Oct 20, 2026, 12 members of Congress had disclosed 52 trades in MCHP (25 buys and 27 sales) in STOCK Act disclosures filed with the House and Senate. The latest public trade is dated Aug 10, 2026.

Trade dateMemberTypeAmount
Aug 10, 2026Ro KhannaBuy$1,001–$15,000
Aug 10, 2026Ro KhannaBuy$50,001–$100,000
Jul 7, 2026Ro KhannaSale$50,001–$100,000
Jun 30, 2026Gilbert CisnerosBuy$1,001–$15,000
Jun 5, 2026Ro KhannaBuy$1,001–$15,000
Jun 2, 2026Ro KhannaBuy$1,001–$15,000
May 1, 2026Ro KhannaBuy$1,001–$15,000
May 1, 2026Ro KhannaSale$1,001–$15,000
Apr 2, 2026Ro KhannaBuy$1,001–$15,000
Mar 27, 2026Alan ArmstrongBuy$1,001–$15,000

Amounts are the ranges members report, not exact values. The STOCK Act gives members up to 45 days to disclose a trade, so trades appear weeks after they are made. See every member’s disclosed trades

2 trades in MCHP disclosed in the last 30 days are in Exent Radar.

Are MCHP insiders buying or selling?

In the 12 months to Oct 20, 2026, MCHP insiders made no open‑market purchases and 21 sales worth $71.1 million, according to SEC Form 4 filings. The last open‑market purchase on record was on Jun 17, 2022.

After the 2 insider purchases of $10,000 or more since 2012, MCHP beat the S&P 500 by an average of 15.5 percentage points over the next 12 months; every one was followed by a beat (a small sample). Across all 17,865 insider purchases in Exent’s study, the average was +17.2% and the median +1.0% against the index.

Q1 ’25
Q2 ’25
Q3 ’25
Q4 ’25
Q1 ’26
Q2 ’26
Q3 ’26
Q4 ’26
DateInsiderRoleValue
Jun 17, 2022Moorthy GaneshPresident & CEO$169,801
Aug 14, 2018Moorthy GaneshCoo$1.0 million
Jun 15, 2011Meyercord Wade FDirector$7,200
Dec 1, 2008Meyercord Wade FDirector$35,600
Nov 19, 2008Meyercord Wade FDirector$17,790

The table lists the latest open‑market purchases on record, leaving out the last 30 days. The chart counts Form 4 purchases and sales by calendar quarter. Purchases are open‑market buys; sales include planned sales under 10b5‑1 trading plans. Do insider buys beat the market?

How much of MCHP is sold short?

As of the Sep 30, 2026 settlement date, 6.26% of MCHP’s float was sold short: 33.3 million shares, or 3.8 days of average trading volume to cover. A year earlier (Oct 15, 2025) it was 4.37%. The median across the 997 US stocks Exent tracks was 4.77%, so MCHP is more heavily shorted than most.

  • Apr 30, 20265.59%
  • May 29, 20266.14%
  • Jun 30, 20267.39%
  • Jul 31, 20266.81%
  • Aug 31, 20266.16%
  • Sep 30, 20266.26%

From FINRA short‑interest reports, filed twice a month; the bars show the short share of the float at each month‑end. Days to cover divides the shares short by the average daily volume. The most shorted stocks

How many institutions own MCHP?

At the end of Q2 2026 (Jun 30, 2026), 1,362 institutions reported holding MCHP in 13F filings, up 127 from the quarter before and up from 1,191 a year earlier. Their reported holdings add up to 100.6% of MCHP’s shares. In the quarter 682 institutions added to their positions and 449 cut them.

1,36213F holders
228new positions
101positions closed
100.6%of shares held by 13F filers

Investment managers with over $100 million in US equities file 13F reports within 45 days of each quarter end, so this is the latest complete quarter. Holdings can add up to more than 100% when shares are lent and counted twice. Which stocks institutions are buying and selling

Is MCHP diluting shareholders?

MCHP’s diluted share count rose 1.2% over the five fiscal years to fiscal 2026 and rose 2.0% in fiscal 2026 alone. Each share now owns a smaller slice of the company. The median change across the 1,005 US stocks Exent tracks was −0.1%.

Stock‑based compensation was $255.4 million in fiscal 2026, 5.4% of revenue. MCHP spent $182.1 million buying back shares, a buyback yield of 0.46% of its market value; stock pay equaled 140.3% of the buybacks.

+2.0%share count, 1 year
+1.2%share count, 5 years
5.4%stock pay as % of revenue
0.46%buyback yield

Weighted‑average diluted shares from MCHP’s annual income statements; stock‑based compensation and buybacks from its cash‑flow statement. Stock dilution and stock‑based compensation, explained

MCHP financial health scores

In Exent’s Oct 20, 2026 snapshot, MCHP’s Altman Z‑score was 4.21, in the safe zone (where 465 of the 794 non‑financial US stocks Exent tracks sit). Its Piotroski F‑score was 7 out of 9; 40% of scored stocks reach 7 or more.

4.21Altman Z‑score: safe zone
7/9Piotroski F‑score

The Altman Z‑score combines five balance‑sheet and earnings ratios into one bankruptcy‑risk score: below 1.81 is the distress zone, 1.81–2.99 grey, above 2.99 safe. It is not meaningful for banks, insurers and REITs. The Piotroski F‑score counts nine yes/no tests of profitability, leverage and efficiency; 8–9 is strong, 0–2 weak. Both come from the latest annual statements. Which stocks have the highest bankruptcy risk?

What MCHP talks about on earnings calls

On its latest earnings call (Aug 6, 2026), MCHP’s executives and analysts mentioned AI 9 times, against 1 on the call before (Feb 5, 2026); the average across 455 S&P 500 calls that quarter was 12.9. After AI, the most mentioned topic was data centers (46). Tariffs and recession did not come up.

MentionsAug ’26Feb ’26Nov ’25Aug ’25
AI911119
AI agents0001
Data centers4615296
Tariffs00314
China0307
Recession0000
  • AI
    Aug ’26
    9
    Feb ’26
    1
    Nov ’25
    11
    Aug ’25
    19
  • AI agents
    Aug ’26
    0
    Feb ’26
    0
    Nov ’25
    0
    Aug ’25
    1
  • Data centers
    Aug ’26
    46
    Feb ’26
    15
    Nov ’25
    29
    Aug ’25
    6
  • Tariffs
    Aug ’26
    0
    Feb ’26
    0
    Nov ’25
    3
    Aug ’25
    14
  • China
    Aug ’26
    0
    Feb ’26
    3
    Nov ’25
    0
    Aug ’25
    7
  • Recession
    Aug ’26
    0
    Feb ’26
    0
    Nov ’25
    0
    Aug ’25
    0

Word counts in the full transcript of each call, prepared remarks and Q&A, newest first. “AI” also counts generative AI and large language models; “AI agents” counts agentic AI. Which companies talk most about AI?

Which ETFs hold MCHP?

As of Oct 20, 2026, 66 of the 304 ETFs Exent tracks held MCHP. Its largest weight is in PSI (Invesco Semiconductors ETF), at 2.94% of the fund.

ETFFundWeight of MCHP
PSIInvesco Semiconductors ETF2.94%
SOXXiShares Semiconductor ETF2.22%
SOXQInvesco PHLX Semiconductor ETF1.87%
DTCRGlobal X Data Center & Digital Infrastructure ETF1.74%
IWPiShares Russell Mid-Cap Growth ETF1.18%
QTUMDefiance Quantum ETF1.07%
VOTVanguard Mid-Cap Growth Index Fund1.00%
SMHVanEck Semiconductor ETF0.83%

Owning several of these funds stacks the same position. How much do VOO, QQQ and VTI overlap?

How much is MCHP’s CEO paid?

Steve Sanghi, MCHP’s Chair of the Board, CEO and President, received total pay of $40.5 million for fiscal 2026, up 89.1% from $21.4 million for fiscal 2025, according to the company’s proxy statement filed with the SEC on Jul 6, 2026. 95% of it came as stock and option awards, valued when they were granted rather than when they pay out. The median CEO pay across the 378 S&P 500 companies Exent tracks was $17.2 million, so MCHP’s CEO earned 2.4 times as much.

Pay componentAmountShare of total
Salary$961,6162.4%
Bonus$14,7300.0%
Stock and option awards$38.3 million94.5%
Incentive plan (cash)$1.2 million3.0%
Other$18,4470.0%
Other top executivesRoleTotal pay, 2026
Richard J. SimoncicChief Operating Officer$4.0 million
J. Eric BjornholtSenior Corporate VP and CFO$2.6 million
Mathew B. BunkerSenior Corporate VP, Operations$2.1 million
Joseph R. KrawczykSenior Corporate VP, Worldwide Client Engagement$1.8 million

Figures from the summary compensation table of the proxy statement; awards count at their grant‑date value, so one large multi‑year grant can make a single year stand out. CEO pay across the S&P 500

The right benchmark for MCHP

Exent matches every holding to the index with the most similar risk. For MCHP that is QQQ (the Nasdaq‑100). Comparing a holding with an index that carries very different risk makes good results look bad and risky ones look clever. Read why the S&P 500 is the wrong benchmark for most portfolios.

Other technology stocks

TickerName5‑year returnVolatility (5y)
AAPLApple Inc.+135.9%28.0%
NVDANVIDIA Corporation+704.3%51.1%
MSFTMicrosoft Corporation+64.0%26.5%
AVGOBroadcom Inc.+570.0%44.7%
MUMicron Technology, Inc.+1,211%51.9%
AMDAdvanced Micro Devices, Inc.+319.9%58.3%
PLTRPalantir Technologies Inc.+611.4%64.4%
ORCLOracle Corporation+45.7%40.4%

Data and methodology

Returns are total returns from month‑end adjusted closing prices (dividends reinvested) through Oct 30, 2026. Crisis drawdowns and trailing maximum drawdowns use daily prices. Analyst coverage counts ratings published in the last 12 months, shown with a 30‑day delay. Full method: Exent methodology.

Company data as of Oct 20, 2026. The move around an earnings report runs from the close before it to the close after it; a price target counts as hit when the stock closed at or beyond it within 12 months (Exent analyst data). Revenue by region and segment, share counts and executive pay come from company filings; insider trades from SEC Form 4, short interest from FINRA, institutional ownership from 13F filings, Congress trades from STOCK Act disclosures filed with the House and Senate, federal contracts from USAspending.gov. Filings from the last 30 days are shown as counts only.

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Check MCHP with Exent Gems

Wall Street’s average MCHP price target is 66.7% above the latest share price. See what the best‑ranked analysts on MCHP say now in Exent Gems.

  1. Exent ranks Wall Street analysts by their past price‑target hit rate and returns, and keeps the best‑ranked few.
  2. Gems shows who the top‑ranked analysts covering MCHP are, their live calls and the median target of only the top‑rated analysts.
  3. Gems flags the stocks where several top‑ranked analysts agree: a starting point for your own research, not a promise.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

No. MCHP returned +208.5% (+11.9% a year) over the 10 years to Oct 30, 2026, versus +316.3% (+15.3% a year) for the S&P 500, including dividends.

Yes. As of Oct 20, 2026, MCHP (Microchip Technology Incorporated) is one of the 503 stocks in the S&P 500. It is also in the Nasdaq-100.

Yes. As of Oct 20, 2026, MCHP (Microchip Technology Incorporated) is one of the 101 stocks in the Nasdaq-100.

MCHP fell −56.5% from peak to trough during the global financial crisis (2007–09), versus −56.5% for the S&P 500.

MCHP fell −49.2% from peak to trough during the covid crash (feb–mar 2020), versus −34.1% for the S&P 500.

MCHP fell −36.2% from peak to trough during the 2022 inflation bear market, versus −25.4% for the S&P 500.

Over the 5 years to Oct 30, 2026, MCHP’s Sharpe ratio was 0.19 and its Sortino ratio 0.33, versus 0.58 and 0.91 for the S&P 500.

MCHP’s 5‑year annualized volatility was 43.5%, higher than the S&P 500’s 17.0%, with a beta of 1.84.

Among large US stocks, the lowest correlations with MCHP over the last 60 months were MRK (−0.17), REGN (−0.11), CME (−0.11). Its correlation with long Treasuries (TLT) was 0.36 and with gold (GLD) 0.06.

MCHP beat the consensus earnings-per-share estimate in 9 of its last 12 quarterly reports through Aug 6, 2026, and the revenue estimate in 7 of 12. The stock moved 6.1% on average, up or down, from the close before each report to the close after it.

Steve Sanghi, MCHP’s Chair of the Board, CEO and President, received $40.5 million in total pay for fiscal 2026, including a $961,616 salary and $38.3 million in stock and option awards valued at grant, according to the proxy statement filed with the SEC on Jul 6, 2026. The median S&P 500 CEO received $17.2 million.

Yes. As of Oct 20, 2026, 12 members of Congress had disclosed 52 trades in MCHP (25 buys and 27 sales) in STOCK Act disclosures filed with the House and Senate.

As of the Sep 30, 2026 settlement date, 6.26% of MCHP’s float was sold short (33.3 million shares, 3.8 days to cover), according to FINRA short-interest reports. A year earlier it was 4.37%.

Yes. MCHP’s diluted share count rose 1.2% over the five fiscal years to fiscal 2026 and rose 2.0% in the latest year. Stock-based compensation was 5.4% of revenue, and buybacks totaled $182.1 million.

What do the best‑ranked analysts say on MCHP now?

Exent ranks Wall Street analysts by their track record. Gems shows who the top‑ranked analysts on MCHP are, their latest calls and the stocks where several of them agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.